Suven Pharmaceuticals
NSEI:SUVENPHAR Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
WA
Consensus Narrative from 2 Analysts
Converting Increased RFPs Into Contracts Will Strengthen Future Prospects
Key Takeaways Strategic acquisitions and diversification into niche markets enhance Suven's revenue potential and improve margins through high-value offerings. Focus on pharma CDMO and global market expansion supports steady growth and stronger customer relationships, boosting long-term earnings potential.
View narrative₹1.47k
FV
17.6% undervalued intrinsic discount77.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
1 day ago author updated this narrative